Literature DB >> 9588750

The original "DAS" and the "DAS28" are not interchangeable: comment on the articles by Prevoo et al.

D M van der Heijde, J W Jacobs.   

Abstract

Mesh：

Year:  1998        PMID： 9588750     DOI： 10.1002/1529-0131(199805)41:5<942::AID-ART26>3.0.CO;2-B

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  9 in total

1.  Is DAS28-CRP with three and four variables interchangeable in individual patients selected for biological treatment in daily clinical practice?

Authors:  Ole Rintek Madsen
Journal:  Clin Rheumatol       Date:  2011-09-29       Impact factor: 2.980

2.  Assessing joint involvement in haemophilia by clinical rheumatologic scores. A pilot study on similarities with subjects with psoriatic arthritis.

Authors:  Matteo Nicola Dario Di Minno; Salvatore Iervolino; Rosario Peluso; Antonio del Puente; Anna Russolillo; Antonio Coppola; Carlo Ruosi; Anna Guida; Raffaele Scarpa; Giovanni Di Minno
Journal:  Clin Rheumatol       Date:  2011-02-16       Impact factor: 2.980

3.  Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?

Authors:  H Mäkinen; H Kautiainen; P Hannonen; T Sokka
Journal:  Ann Rheum Dis       Date:  2005-06-07       Impact factor: 19.103

4.  Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed.

Authors:  L B A van de Putte; C Atkins; M Malaise; J Sany; A S Russell; P L C M van Riel; L Settas; J W Bijlsma; S Todesco; M Dougados; P Nash; P Emery; N Walter; M Kaul; S Fischkoff; H Kupper
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

5.  In vitro and ex vivo effect of hyaluronic acid on erythrocyte flow properties.

Authors:  A Luquita; L Urli; M J Svetaz; A M Gennaro; M E Giorgetti; G Pistone; R Volpintesta; S Palatnik; M Rasia
Journal:  J Biomed Sci       Date:  2010-02-12       Impact factor: 8.410

6.  Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial).

Authors:  S M M Verstappen; J W G Jacobs; M J van der Veen; A H M Heurkens; Y Schenk; E J ter Borg; A A M Blaauw; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2007-05-22       Impact factor: 19.103

7.  Health-related quality of life and disease activity in rheumatoid arthritis.

Authors:  Gholam Hossein Alishiri; Noushin Bayat; Ahmad Salimzadeh; Amirhossein Salari; Seyed Morteza Hosseini; Shadi Rahimzadeh; Shervin Assari
Journal:  J Res Med Sci       Date:  2011-07       Impact factor: 1.852

Review 8.  Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility.

Authors:  M F Bakker; J W G Jacobs; S M M Verstappen; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 27.973

9.  Validation of methods for converting the original Disease Activity Score (DAS) to the DAS28.

Authors:  Lewis Carpenter; Sam Norton; Elena Nikiphorou; Patrick Kiely; David A Walsh; Josh Dixey; Adam Young
Journal:  Rheumatol Int       Date:  2018-10-27       Impact factor: 2.631
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.